Reading the tape
NYSE: AVNS
Avanos Medical, Inc.
Healthcare · Medical - Devices
Market Cap
$1.15B
52w High
$24.75
52w Low
$9.30
P/E
-16.48
Volume
211.72K
Outstanding Shares
46.67M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
1Y Price: 102.3%Revenue (TTM): 3.87%FCF (TTM): -93.42%P/E: 0th pct
What changed
The stock rose 102.3% over the last year. Revenue grew 3.87% over the trailing twelve months. Operating margin moved from 7.63% to -8.38%. Free cash flow declined 93.42% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -8.38%. A decisive move in revenue — currently up 3.87% — would be the clearest signal to resolve the ambiguity.
Company profile
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
CEODavid C. Pacitti
SectorHealthcare
IndustryMedical - Devices
Employees2,227
IPO dateOct 21, 2014
Valuation
Forward P/E—
EV/EBITDA-16.88
Enterprise value$560.37M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth8.78%
Gross margin49.36%▼10.22%vs FY2024
Operating margin-8.38%▼251.06%vs FY2024
ROE-8.73%▲81.56%vs FY2024
Analyst consensus
RatingHold
Target price$23.00▼6.90%
1
Buy
6
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $0.14 · Revenue est $170M
View